Current management of the patient with autonomously functioning nodular goiter

Area of Science:

• Endocrinology
• Nuclear Medicine
• Surgical Oncology

Background:

• Autonomously functioning thyroid nodules (AFTNs) are TSH-independent, concentrating radionuclides more than normal thyroid tissue.
• These nodules can present as solitary or multiple (Plummer's disease), with hormone secretion determining euthyroid or hyperthyroid status.

Observation:

• Diagnostic tools include 99mTc thyroid scans, T4 RIA, T3 uptake, FTI, TSH RIA, and T3 RIA.
• Solitary nodules in adults typically progress slowly; toxicity is rare in nodules <2.5 cm but common in those ≥3 cm, especially in older patients.
• Hyperfunctioning nodules in children (<18 years) progress rapidly and warrant prompt thyroid lobectomy.

Findings:

• Treatment for solitary nodules is based on size, function, and patient age.
• Surgery and radioactive iodine are effective treatments for AFTNs.
• Subtotal thyroidectomy is preferred for toxic multinodular goiter for rapid hyperthyroidism control.

Implications:

• Early diagnosis and treatment are crucial, especially in pediatric patients.
• Therapeutic options for AFTNs include surgery, radioactive iodine, and antithyroid drugs.
• Management strategies should be tailored to nodule characteristics and patient demographics.